Hutch News

Hutch News

Stories tagged 'brain cancer'

Brain cancer subtype caused by single gene fusion

Hutch researchers create genetically relevant model to examine the biology of supratentorial ependymomas

June 26, 2018 | By Sabrina Richards / Fred Hutch News Service

Dr. Eric Holland and colleagues create a genetically relevant model to examine the biology of supratentorial ependymomas, a common brain cancer in children.

View story >


Nanoparticles take immunotherapy in new direction

Hutch scientist to use nanoparticles to reprogram macrophages to tackle brain tumors

May 30, 2018 | By Sabrina Richards / Fred Hutch News Service

Dr. Fan Zhang has received funding from the American Brain Tumor Association to develop nanoparticles that can tackle a type of brain cancer called glioblastoma.

View story >


Study shows how glioblastomas get a leg up

New computational method sheds light on how cancer-contributing genes make brain tumors more aggressive and radiation-resistant

April 13, 2018 | By Sabrina Richards / Fred Hutch News Service

Researchers at Fred Hutch and the Dana-Farber Cancer Institute have developed a computational method that sheds light on how cancer-contributing genes make brain tumors more aggressive and radiation-resistant.

View story >


6 things to know about glioblastoma

Following Sen. John McCain’s diagnosis, Fred Hutch experts offer ‘the long view’ on brain cancer research

July 21, 2017 | By Mary Engel / Fred Hutch News Service

Our experts at Fred Hutchinson Cancer Research Center offer the long view on glioblastoma diagnosis, treatment and research in light of Sen. John McCain's recent diagnosis.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

May 25, 2017

A team of Fred Hutch researchers led by principal investigator Dr. Eric Holland has received $400,000 for a two-year pilot study to test several novel immunotherapy approaches for glioma, an aggressive brain cancer. The study was made possible by the generous support of the Bezos family, which since 2009 has donated and leveraged more than $40 million to Fred Hutch for immunotherapy research.

View story >


How mutations in a single gene alter the course of a deadly brain cancer

New laboratory study of glioma links more aggressive immune response to poorer prognosis

May 23, 2017 | By Sabrina Richards / Fred Hutch News Service

A new study in the aggressive brain cancer known as glioma found that higher levels of immune cells correlated with poorer survival.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.